期刊文献+

辛伐他汀对C反应蛋白诱导的单核细胞白细胞介素-6合成的影响 被引量:5

Effects of simvastatin on interleukin-6 synthesis in monocytes stimulated by C-reactive protein
暂未订购
导出
摘要 目的 探讨辛伐他汀对C反应蛋白 (C reactiveprotein ,CRP)诱导的人外周血单核细胞白细胞介素 6 (interleu kin 6 ,IL 6 )合成的影响 ,观察辛伐他汀的抗炎作用。方法 密度梯度离心法分离人外周血单核细胞 ,应用酶联免疫吸附测定法观察CRP刺激单核细胞产生IL 6的时间 剂量效应 ,其峰值与辛伐他汀抑制剂组比较。结果 CRP刺激IL 6合成开始的时间是 4h ,呈时间依赖性和剂量依赖性 ,在 2 4h达高峰。辛伐他汀 (10 - 8~ 10 - 6 mol L)呈剂量依赖性抑制单核细胞IL 6合成。结论 辛伐他汀能抑制CRP诱导的单核细胞IL 6合成 ;辛伐他汀对炎症反应的抑制作用提示该药物可用于预防和治疗冠心病。 Objective To evaluate the effect of simvastatin on interleukin-6 (IL-6) production in human monocytes stimulated by C-reactive protein(CRP) and to assess the influence of simvastation on monocyte inflammatory reaction.Methods Monocytes were isolated by density gradient method from blood of healthy volunteers.IL-6 production(by ELISA) stimulated by 20 μg/ml CRP for 2, 4, 8, 16 and 24 h or by 1 μg/ml, 5 μg/ml, 10 μg/ml, 20 μg/ml CRP for 24 h was measured The peaks were compared with those in the group inhibited by simvastatin(10 -8 to 10 -6 mol/L).Results IL-6 was produced after stimulation with CRP for 4 h. The effects of CRP were dose-dependent and time-dependent, reaching peak at 24 h. Simvastatin (10 -8 to 10 -6 mol/L) inhibited the production of IL-6 in a dose-dependent manner.Conclusion Simvastatin can inhibit the production of IL-6,suggesting that it can be used in clinical prevention and treatment of coronary heart disease.
出处 《中华老年心脑血管病杂志》 CAS 2003年第3期189-191,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 炎症 白细胞介素6 单核细胞 冠状动脉疾病 药物疗法 inflammation interleukin-6 monocytes coronary disease drug therapy
  • 相关文献

参考文献11

  • 1Libby P. Ridker PM. Novel inflammatory markers of coronary risk:theory versus praetice[J]. Circulation, 1999,100:1148-1150.
  • 2Ross R. Atherosclerosis --- an inflammatory disease[J]. N Engl J Med 1999,340:115-126.
  • 3Masen A. Inflammation, atherosclerosis and ischemic events --- exploring the hidden side of the moon[J]. N Eng J Med, 1997:336:1014-1016.
  • 4Rus HG, Vlaicu R, Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human atheresclerotic wall[J]. Atherosclerosis , 1996,127: 263-271.
  • 5Yudkin JS, Kumari M, Humphries SE, et al. Inflammation, obesity, stress and coronary heart disease: is interleukin.6 the link[J]?Atherosclerosis, 2000,148:209-214.
  • 6Skretting G, Gjemes E, Prydz H. Regulation of lecithin:Cholesterol acyltransferase by TGF-beta and interleukin-6[ J]. Biochem Biophys Acta, 1995,1255 : 267-272.
  • 7Biasucci LM, Vitelli A, Livzzo G, et al. Elevated levels of interleukin-6 in unstable angina[J]. Circulation, 1996,94:874-877.
  • 8Ridker PM, Rifai N, Stampfer M J, et al. Plasma concentration interleukin-6 and the risk eft future myocardial iffarction among apparently healthy men[J]. Circulation, 2000,101 : 1767-1772.
  • 9Weber C, Erl w, Weber KSC, et al. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesives of monocytes isolated from patients with hypercholesterolemia[ J]. J Am coll Cardiol,1997,30:1212-1217.
  • 10Scalia R, Gooszen ME, Jones SP, et al. Simvastatin exerts both antiinflammatory and cardioprotective effects in apolipoprotein E-deficient mice[J]. Circulation, 2001, 103:2598-2603.

同被引文献56

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部